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Abstract
Background: A link between IgA nephropathy and Crohn’s disease has recently been reported. Other researchers
hypothesize that intestine-derived IgA complexes deposit in glomerular mesangial cells, eliciting IgA nephropathy.
Intestinal mucosal plasma cells mainly secrete IgA2. Nevertheless, IgA1 deposition is strongly implicated as being the
primary cause of IgA nephropathy.
Case presentation: A 46-year-old Japanese man developed IgA nephropathy 29 years ago, following tonsillectomy.
As a result, a normal urinalysis was obtained. The patient previously suffered Crohn’s disease followed by urinary
occult blood and proteinuria six years ago. Exacerbation of IgA nephropathy was highly suspected. Therefore a
renal biopsy was performed. A diagnosis of exacerbation of IgA nephropathy with mesangial cell proliferation and
fibrotic cellular crescent was based upon the pathological findings. The patient exhibited a positive clinical course
and eventually achieved a remission with immunosuppressive therapy including prednisolone treatment.
Immunostaining for the detection of IgA subtypes was performed on both of his kidney and excised ileum.
The results revealed IgA1 and IgA2 deposition by submucosal cells in intestine. Furthermore, IgA1 deposition of
mesangial areas in the patient’s kidney, indicated an association of IgA1 with the exacerbation of IgA
nephropathy.
Conclusion: This case represents the possibility that the intestine-derived IgA1 can be the origin of galactose-deficient
IgA which is known to cause IgA nephropathy exacerbation.
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Background
IgA1 is one of the subtypes of IgA produced in bone mar-
row, tonsils and respiratory tracts. Also, it can be found
predominantly in the glomeruli of patients with IgA ne-
phropathy. This observation supports the idea of using
tonsillectomy as an effective therapeutic intervention for
IgA nephropathy. Alternatively, intestinal mucosal plasma
cells mainly secrete IgA2 (approximately 60 % in mucosal
cells), another subtype of IgA, rather than IgA1 [1].
Recent reports have indicated a strong link between
IgA nephropathy and Crohn’s disease. Several hypoth-
eses exist, indicating this, however the underlying
mechanism is still unknown. One can speculate that
intestine-derived IgA is possibly deposited in glomeru-
lar mesangial cells, eliciting IgA nephropathy [2–4].
Here, we present a case report of a patient suffering
from exacerbated IgA nephropathy associated with
Crohn’s disease, who had tonsillectomy 29 years ago.
We performed immunohistochemical analysis in renal
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biopsy and excised ileum specimen to determine
whether it was IgA1 or IgA2 that was specifically associ-
ated with the exacerbation of IgA nephropathy. The re-
sults indicated that IgA1, not IgA2, is the causative
source of IgA nephropathy exacerbation. This indicates
a link between inflammatory intestine-derived IgA1 and
IgA nephropathy.
Case presentation
A 46-year-old Japanese man suffered from IgA nephropa-
thy, prior to be given tonsillectomy 29 years ago. Urinaly-
sis revealed neither hematuria nor proteinuria after
surgical removal of his tonsils. The patient experienced a
sudden onset of Crohn’s disease 6 years ago. As a result,
he was administered several medications to alleviate the
symptoms of Crohn’s disease; initially, 5-aminosalicylic
acid (ASA). Due to the unstable state of Crohn’s disease,
an ileum resection was performed. Additionally, prednis-
olone, azathioprine (AZA) and infliximab were eventually
incorporated in his treatment. Despite therapeutic drug
intervention, his abdominal symptoms including diarrhea
persisted. Consequently, he was then referred to our hos-
pital because of proteinuria and urinary occult blood. An
otolaryngologic check-up revealed no sinusitis, and
residual tonsil and gross physical examination provided
no remarkable findings. Abdominal CT displayed bilateral
slightly atrophic kidneys. A laboratory workup showed a
mild renal dysfunction (creatinine; 1.37 mg/dl, creatinine
clearance; 69.1 ml/min), without any other abnormal find-
ings of blood (IgG, 1492.3 mg/dl; IgA, 223.2 mg/dl; IgM,
33.8 mg/dl; C3, 101.4 mg/dl; C4, 22.7 mg/dl; CRP,
0.09 mg/dl, anti-streptolysin O, 109 IU/ml; normal range:
0–239; anti-streptokinase, ×1280; normal: < ×2560). Sero-
logic tests for hepatitis B and C and HIV were all negative.
Urinalysis showed proteinuria (2+) and occult blood (2+),
with 5–9 red blood cells and < 1 white blood cells per
high-power field in sediment. Twenty four-hour urine
collection revealed a protein level of 1.44 g/day. To detect
occult blood (1+ to 2+) and continuous proteinuria (2+ to
3+), a renal biopsy was performed to examine whether
IgA nephropathy relapsed or other glomerular diseases
occurred. Immunofluorescent examination of mesangial
cells exhibited intense (3+) mesangial granular staining of
IgA (Fig. 1a). Moderate (2+) granular staining of IgM and
C3 in the mesangial area was observed. Examination by
light microscopy revealed expansion of mesangial cells
and fibrotic cellular crescents (Fig. 1b). These findings are
consistent with IgA nephropathy. Given these observa-
tions, prednisolone of 40 mg/day was started, with 10–
20 % reduction monthly and with every subsequent
visit. After 1-year of treatment (5 mg/day dosage of
prednisolone is continued), his urine protein levels
decreased to 0.1 to 0.3 g/gCr, with no occult blood was
detected.
Due to his clinical course, we strongly suspected the
association between the occurrence of intestinal inflam-
matory disease and the exacerbation of IgA nephropa-
thy. Based on the predominance of IgA2 subtype found
in the intestinal immune system, the patient’s excised
ileum and biopsied kidney species were examined to de-
termine whether IgA2 subtype might be mainly involved
in the exacerbation of IgA nephropathy. Immunohisto-
chemical staining demonstrated that lymphocytes and
plasma cells had infiltrated on the inflammatory ileum
mucosa. In particular, at the layer of submucosa, total
IgA, IgA1 and IgA2 positive cells were widely distributed,
a number of IgA1 positive cells were observed as well as
IgA2 positive cells (Fig. 2). Alternatively, the patient’s
kidney sample demonstrated that IgA1 was mainly
deposited granular to mesangial areas (Fig. 3). These
results raised the possibility that inflammatory ileum
derived IgA1 in our patient suffering from Crohn’s
disease was in fact associated with the exacerbation of
IgA nephropathy.
Conclusions
Renal or urologic complications are common in Crohn’s
disease (up to 25 % of diagnosed patients) [5]. However,
most of patients affected with Crohn’s disease exhibit
urologic complications, such as nephrolithiasis with cal-
cium oxalate or urate stones, enterovesical fistulas and
ureteral obstruction [6]. Renal parenchymal dysfunction
of tubulointestitial nephritis (TIN) occurs in 1 out of
500 patients who undertake 5-ASA, which is one of the
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Fig. 1 Histological findings of the renal tissues. a IgA, (b) Mesangial matrix expansion and fibrocellular crescent formations were observed in
glomeruli with periodic acid-Schiff (PAS) staining (400×). c Slight changes of interstitial fibrosis and arteriole sclerosis with Masson staining (40×)
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key drugs prescribed for inflammatory bowel disease
(IBD) [7]. 5-ASA induced TIN is reported to appear
mostly within 12 months of the drug administration, but
the prolonged phase of 5-ASA treatment also can cause
TIN. Early and definite diagnosis of nephropathy with
IBD should be confusing because their cases are gener-
ally medicated with 5-ASA for a long time.
IgA nephropathy is the most common type of glom-
erulonephritis and it is caused by primary or secondary
pathogen disease such as seronegative arthritis, cirrho-
sis, celiac disease, vasculitis and HIV [8]. Although the
effect of tonsillectomy on IgA nephropathy is still con-
troversial, several reports suggest its practical efficacy
at the present time. The retrospective study showed
that tonsillectomy had an effect on renal outcome [9].
The decrease level of proteinuria in steroid pulse ther-
apy with or without tonsillectomy was significant [10].
Reports of IgA nephropathy associated with Crohn’s
disease are increasing. A retrospective review of 83 kid-
ney biopsies with IBD report that the most common
diagnosis was IgA nephropathy (24 %), followed by
interstitial nephritis (19 %) which was suspected of 5-
ASA relation, and arterionephrosclerosis (12 %) [11]. In
that review, it was not clearly mentioned whether the
occurrence of IgA nephropathy in Crohn’s disease was
different from that in ulcerative colitis. The mechanism
of the complication between IgA nephropathy and
Crohn’s disease has been discussed in three points.
First, the systemic absorption of IgA at the intestine
mucosal inflammation site is associated with IgA
nephropathy [2–4]. Second, the possible involvement of
a common genetic factor; especially human leukocyte
antigen (HLA)-DR1 has been the suspected factor that
provides a link between Crohn’s disease and IgA ne-
phropathy [12, 13]. Third, abnormal T helper lympho-
cyte is a factor that may contribute to the pathogenesis
associated with these two diseases [14].
Further experiments are needed to confirm these hy-
potheses. On the other hand, in Crohn’s disease, intes-
tinal mucosal inflammation is thought to lead to the
systemic absorption of antigens and bacteria, and high
serum levels of IgA and IgG [2]. Alternatively, increased
intestinal mucosal permeability was demonstrated in IgA
nephropathy [15]. The association of the etiology of
Crohn’s disease after tonsillectomy has been reported
[16], yet, it is not clear whether this association is
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Fig. 2 Immunohistological findings of the intestine tissues. Exacerbated intestine mucosal infiltration of lymphocytes and plasma cells with






Fig. 3 Immunofluorescent histological findings of the glomeruli.
Immunostaining of total IgA (a), IgA1 (b), IgA2 (c) in kidney glomeruli
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applicable to our case or not. During the term of exacer-
bation of bowel disease, IgA nephropathy deteriorates or
clinically evoked. Treatment of bowel disease with either
immunosuppression therapy or bowel resection is asso-
ciated with a clinical remission of IgA nephropathy [17].
These clinical observations support that a high level of
systemic IgA derived from the ileum tract leads to the
onset of IgA nephropathy. We hypothesized that
intestine-derived IgA2 would react to this mechanism,
since mucosa of lower gastrointestinal tract secreted
mostly IgA2 than IgA1. Nonetheless, in this case, IgA1
deposition, but not IgA2 deposition, in kidney glomeru-
lar mesangial sites was observed. The galactose-deficient
IgA1 is recognized as being the likely cause of IgA ne-
phropathy [18, 19]. IgA1 producing cells are known to
increase in the intestine of IBD [20], which also provides
the potential answer to why intestine-derived abnormal
sugar-chain IgA1 is a causative agent of IgA nephropa-
thy. In conclusion, there appears to be a link between
Crohn’s disease, IgA nephropathy and galactose-deficient
IgA1 secreted by the intestine, and all may be confound-
ing factors that contribute to the onset or exacerbation
of IgA nephropathy.
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